105 related articles for article (PubMed ID: 15207989)
1. Processes of care in cervical and breast cancer screening and follow-up--the importance of communication.
Zapka JG; Puleo E; Taplin SH; Goins KV; Ulcickas Yood M; Mouchawar J; Somkin C; Manos MM
Prev Med; 2004 Jul; 39(1):81-90. PubMed ID: 15207989
[TBL] [Abstract][Full Text] [Related]
2. Adherence characteristics after abnormal screening results between mammogram and Papanicolaou test groups.
Fang SY; Shu BC
Cancer Nurs; 2009; 32(6):437-45. PubMed ID: 19816157
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report.
Puleo E; Zapka JG; Goins KV; Yood MU; Mouchawar J; Manos M; Somkin C; Taplin S
Eval Health Prof; 2005 Sep; 28(3):310-27. PubMed ID: 16123260
[TBL] [Abstract][Full Text] [Related]
4. Trends in abnormal cancer screening results in the United States of America.
Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
[TBL] [Abstract][Full Text] [Related]
5. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
[TBL] [Abstract][Full Text] [Related]
6. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women.
Buki LP; Jamison J; Anderson CJ; Cuadra AM
Cancer; 2007 Oct; 110(7):1578-85. PubMed ID: 17696119
[TBL] [Abstract][Full Text] [Related]
7. Breast and cervical cancer screening in Spain and predictors of adherence.
Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
9. Physician recommendation for papanicolaou testing among U.S. women, 2000.
Coughlin SS; Breslau ES; Thompson T; Benard VB
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
[TBL] [Abstract][Full Text] [Related]
10. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
[TBL] [Abstract][Full Text] [Related]
11. Breast and cervical cancer screening in an inner-city medical walk-in clinic: taking advantage of an often missed opportunity.
Doyle JP; Parker RM; Jacobson TA; McNagny SE
Am J Prev Med; 1996; 12(5):345-50. PubMed ID: 8909645
[TBL] [Abstract][Full Text] [Related]
12. What predicts adherence to follow-up recommendations for abnormal Pap tests among older women?
Coker AL; Eggleston KS; Meyer TE; Luchok K; Das IP
Gynecol Oncol; 2007 Apr; 105(1):74-80. PubMed ID: 17157363
[TBL] [Abstract][Full Text] [Related]
13. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women.
Echeverria SE; Carrasquillo O
Med Care; 2006 Aug; 44(8):788-92. PubMed ID: 16862042
[TBL] [Abstract][Full Text] [Related]
14. Associations in breast and colon cancer screening behavior in women.
Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
[TBL] [Abstract][Full Text] [Related]
15. Validity of women's self-reports of cancer screening test utilization in a managed care population.
Caplan LS; McQueen DV; Qualters JR; Leff M; Garrett C; Calonge N
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1182-7. PubMed ID: 14652278
[TBL] [Abstract][Full Text] [Related]
16. Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts.
Zapka JG; Puleo E; Taplin S; Solberg LI; Mouchawar J; Somkin C; Geiger AM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):46-54. PubMed ID: 16287885
[TBL] [Abstract][Full Text] [Related]
17. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
Koval AE; Riganti AA; Foley KL
N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
[TBL] [Abstract][Full Text] [Related]
18. Abnormal Pap screening among Mexican-American women: impediments to receiving and reporting follow-up care.
Hunt LM; de Voogd KB; Akana LL; Browner CH
Oncol Nurs Forum; 1998; 25(10):1743-9. PubMed ID: 9826840
[TBL] [Abstract][Full Text] [Related]
19. Correlates of intent to seek unnecessary pap tests among elderly women.
Zhang Y; Borders TF; Rohrer JE
Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
[TBL] [Abstract][Full Text] [Related]
20. Women's mammography experience and its impact on screening adherence.
Tang TS; Patterson SK; Roubidoux MA; Duan L
Psychooncology; 2009 Jul; 18(7):727-34. PubMed ID: 19035468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
